cardiovascular risk – Page 3 – Communicable Diseases Research

A four-month follow-up study of Cardiac performance in patients hospitalized with COVID-19 in a Tertiary Care Government Medical Hospital

Conference abstract

Published on 2022-03-012022-10-05
Journal: International Journal of Infectious Diseases [Category] 바이오마커,

Safety and tolerability of hydroxychloroquine in health care workers and first responders for the prevention of COVID-19: WHIP COVID-19 Study

Randomized Controlled Trial

Published on 2022-03-012022-10-04
Journal: International Journal of Infectious Diseases [Category] MERS, SARS, 임상,

[키워드] acquisition Adverse adverse event ARMS Autoimmune diseases cardiovascular risk Chemoprophylaxis confirmed COVID-19 case COVID-19 determine Efficacy end point enrolled evaluate event Future group HCQ HCW Health care Health care worker health care workers high-risk population highest Hospitalization Hydroxychloroquine hydroxychloroquine treatment Intervention Laboratory occurred participant Placebo placebo-controlled clinical study polymerase chain positive prospective cohort Randomized randomized placebo-controlled trial randomized trial required Responder responders Result risk Safe Safety SARS-CoV-2 SARS-COV-2 infection the epidemic Tolerability Trial was used
[DOI] 10.1016/j.ijid.2021.12.343 PMC 바로가기 [Article Type] Randomized Controlled Trial

Effect of statin therapy on SARS-CoV-2 infection-related mortality in hospitalized patients

Observational Study

Published on 2022-02-162022-10-05
Journal: European heart journal. Cardiovascular pharmacothe [Category] COVID19(2023년), SARS, 임상,

One-Year Impact of COVID-19 Lockdown-Related Factors on Cardiovascular Risk and Mental Health: A Population-Based Cohort Study

Article

Published on 2022-02-012022-10-29
Journal: International Journal of Environmental Research an [Category] Coronavirus, COVID19(2023년), MERS, SARS,

Anxiety, home blood pressure monitoring, and cardiovascular events among older hypertension patients during the COVID-19 pandemic

Clinical Trial

Published on 2022-01-212022-10-04
Journal: Hypertension research : official journal of the Ja [Category] MERS, 임상,

Metabolic biomarkers related to cardiac dysfunction in metabolic-dysfunction-associated fatty liver disease: a cross-sectional analysis

Article

Published on 2022-01-182022-10-04
Journal: Nutrition & Diabetes [Category] 바이오마커,

Cardiovascular Risk After SARS-CoV-2 Infection Is Mediated by IL18/IL18R1/HIF-1 Signaling Pathway Axis

SARS-CoV-2 감염 후 심혈관 위험은 IL18/IL18R1/HIF-1 신호 경로 축에 의해 매개됩니다

Immunology

Published on 2022-01-052022-09-11
Journal: Frontiers in Immunology [Category] 유전자 메커니즘, 치료기술, 치료제,

[키워드] activate activated Activation Algorithm Analysis Aneurysm aneurysms Atherosclerosis axis cardiovascular cardiovascular risk Cell cell types changes in characterized choice Compound COVID-19 COVID-19 infection detect Epigenetic expected functional gene co-expression network HIF-1 HIF-1 signaling pathway HIF1a hypoxia identify IL-18 IL18 IL18R1 Infection Inference Intercellular communication interleukin locus Macrophage macrophages MAP2K1 mechanism Mediated MEK inhibitor Methylation NF-κB nucleus objective pathway Pathways PBMC phenotype phenotypic Potential promote promoted Proteins Proteomic analysis Regulation Regulatory Regulon Result SARS-CoV-2 SARS-COV-2 infection scRNA-seq Signaling signaling pathway smooth muscle therapeutic compound therapeutic target Treatment type I interferon type I interferon pathway vascular smooth muscle vascular smooth muscle cells VIPER was used WGCNA with COVID-19
[DOI] 10.3389/fimmu.2021.780804 PMC 바로가기 [Article Type] Immunology

Fighting the pandemic with collaboration at heart: Report from cardiologists in a COVID-19-dedicated Portuguese intensive care unit

협력을 중심으로 전염병 퇴치: COVID-19 전담 포르투갈 집중 치료실의 심장 전문의의 보고서

Article

Published on 2021-12-012022-09-11
Journal: Revista portuguesa de cardiologia [Category] SARS, 치료기술,

[키워드] Adult patients age analyzed cardiac marker Cardiac markers Cardiologia Cardiology cardiovascular risk Care changed coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 prognosis Cuidados intensivos Cuidados multidisciplinares de novo Decision making died discharged dysfunction dyslipidemia English Extra-corporeal membrane oxygenation Fighting followed by hypertension ICU intensive care male Manifestations mechanical ventilation membrane mobilization Multidisciplinary care myocardial injury N-terminal N-terminal pro-B-type natriuretic peptide Nova NT-proBNP one patient Oxigenação por membrana extracorporal pandemic Patient Patient care patients with COVID-19 pelo peptide pro-B-type natriuretic peptide report required Respiratory illness severe COVID-19 Spread Takotsubo the disease Vasopressor vasopressor support
[DOI] 10.1016/j.repce.2021.11.009 PMC 바로가기 [Article Type] Article

Cardiovascular health and risk of hospitalization with COVID-19: A Mendelian Randomization study

Original Research Article

Published on 2021-11-192022-10-30
Journal: JRSM Cardiovascular Disease [Category] COVID-19,

[키워드] association blood pressure BMI body mass index CAD cardiovascular cardiovascular disease cardiovascular risk cardiovascular risk factors Causal confidence interval Confidence intervals controls Coronary artery disease COVID-19 COVID-19 diagnosis determine Diagnosis diagnosis of COVID-19 Evidence examined genome-wide association GWAS GWAS meta-analysis Health Hospital admission Hospitalization increase in Laboratory mendelian randomization Meta-analysis observational study Odds ratio performed predicted reported residual confounding Result risk risk factor severe COVID-19 severity severity of COVID-19 Socioeconomic factor type 2 diabete with COVID-19
[DOI] 10.1177/20480040211059374 PMC 바로가기 [Article Type] Original Research Article

Low eGFR Is a Strong Predictor of Worse Outcome in Hospitalized COVID-19 Patients

Article

Published on 2021-11-092022-10-30
Journal: Journal of Clinical Medicine [Category] COVID-19,

[키워드] 95% CI Acute kidney injury Admission age AKI anti-platelet treatment blood glucose cardiovascular comorbidities cardiovascular risk chronic Chronic kidney disease CKD Clinical course Clinical deterioration co-morbidities component consecutive sample COVID-19 death died Elderly patient evaluate evaluated event glomerular filtration rate hazard ratio high risk Hospitalization hospitalized COVID-19 patients hospitalized patients ICU independent index Kidney disease LDH multivariate model occurred outcome Patient Prevent Primary outcome Probability reached reduced Respiratory failure Secondary outcomes serum creatinine significantly significantly higher SpO2 statistical analysis Strong Supportive treatment two group Univariate analysis whole sample
[DOI] 10.3390/jcm10225224 PMC 바로가기 [Article Type] Article